{
    "Trade/Device Name(s)": [
        "AllTest Multi-Drug Urine Test Cup",
        "AllTest Multi-Drug Rapid Urine Test Cup"
    ],
    "Submitter Information": "Hangzhou AllTest Biotech Co., Ltd.",
    "510(k) Number": "K250727",
    "Predicate Device Reference 510(k) Number(s)": [
        "K244043"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "PTH",
        "NGL",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "QBF",
        "NGM",
        "QAW",
        "NFW"
    ],
    "Summary Letter Date": "March 9, 2025",
    "Summary Letter Received Date": "March 11, 2025",
    "Submission Date": "March 26, 2025",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Opiate Test System",
        "Benzodiazepine Test System",
        "Cocaine and cocaine metabolite test system",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Propoxyphene test system",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Benzodiazepine",
        "Cocaine",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Nortriptyline",
        "Marijuana",
        "Fentanyl",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine",
        "Tramadol",
        "Propoxyphene",
        "6-monoacetylmorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Test cup"
    ],
    "Instrument(s)/Platform(s)": [
        "AllTest Multi-Drug Urine Test Cup",
        "AllTest Multi-Drug Rapid Urine Test Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Lateral flow immunoassay"
    ],
    "Submission Type(s)": [
        "Test cup"
    ],
    "Document Summary": "FDA 510(k) summary for the AllTest Multi-Drug Urine Test Cup and AllTest Multi-Drug Rapid Urine Test Cup\u2014lateral flow immunochromatographic OTC urine drug screening devices for multiple drugs of abuse.",
    "Indications for Use Summary": "For qualitative and simultaneous detection of multiple drugs and drug metabolites in human urine as an over-the-counter in vitro diagnostic screening test, providing only preliminary results; intended for single or combination drug testing.",
    "fda_folder": "Toxicology"
}